SDF2L1 and fatty liver disease: Moreover, expression of hepatic Sdf2l1 is decreased in obese and diabetic db/db mice and humans, and the suppression of hepatic Sdf2l1 expression results in insulin resistance and hepatic steatosis with a sustained ER stress [17].